Výsledky vyhledávání - "Vojvodic, R. W."

LateTIME: A Phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction

Autor: Traverse, J. H., Henry, T. D., Vaughan, D. E., Ellis, S. G., Pepine, C. J., Willerson, J. T., Zhao, D. X. M., Simpson, L. M., Penn, M. S., Barry J. Byrne, Perin, E. C., Gee, A. P., Hatzopoulos, A. K., Mckenna, D. H., Forder, J. R., Taylor, D. A., Cogle, C. R., Baraniuk, S., Olson, R. E., Jorgenson, B. C., Sayre, S. L., Vojvodic, R. W., Gordon, D. J., Skarlatos, S. I., Moyé, L. A., Simari, R. D.

Publikováno v: Scopus-Elsevier

A realistic goal for cardiac cell therapy may be to attenuate left ventricular remodeling following acute myocardial infarction to prevent the development of congestive heart failure. Initial clinical trials of cell therapy have delivered cells 1 to

Vyhledávací nástroje:

Upřesnit hledání